Cointime

Home / Caxton Advantage Life Sciences Fund / investments

Caxton Advantage Life Sciences Fund

investment firm

Investments

Number of Investments
Number of Lead Investments
14
6
Caxton Advantage Life Sciences Fund has made 14 investments. Their most recent investment was on Nov 20, 2020, when VIVUS, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Nov 20, 2020 VIVUS Post-IPO Equity — Biopharma Yes
Aug 4, 2014 Mevion Medical Systems Private Equity（PE） — Biotechnology —
Jun 25, 2013 Mevion Medical Systems Private Equity（PE） — Biotechnology —
Dec 17, 2012 Regado Biosciences Series E — Biotechnology —
Aug 24, 2010 Gemin X Pharmaceuticals Series E — Biotechnology Yes
Apr 20, 2010 Gemin X Pharmaceuticals Series D — Biotechnology Yes
Dec 17, 2009 Regado Biosciences Series D — Biotechnology —
Apr 7, 2009 Sunesis Pharmaceuticals Post-IPO Equity — Biotechnology —
Jan 1, 2009 Mevion Medical Systems Series Unknown — Biotechnology —
Aug 14, 2008 Anthera Pharmaceuticals Series Unknown — Biotechnology Yes
Jul 3, 2008 Gemin X Pharmaceuticals Series C — Biotechnology Yes
Dec 20, 2007 Corthera Series C — Biotechnology —
Oct 8, 2007 Mevion Medical Systems Series C — Biotechnology —
Mar 27, 2007 Regado Biosciences Series C — Biotechnology Yes
Cointime
İçerikler
Şirket.